Guerbet is a French pharmaceutical group that has been supporting healthcare professionals specialized in diagnostic and interventional imaging since 1926. Guerbet develops and markets contrast media, delivery systems, medical devices, and related solutions adapted to their needs.
Guerbet’ strategy to strengthen Interventional Imaging has already been in place for several years and is bolstering with the recent creation of a dedicated franchise for Women’s Health built on an innovative Product Portfolio dedicated to female fertility management & breast cancer.
Guerbet Women's Health products include Lipiodol® Ultra Fluid, an iodinated contrast agent (based on poppy seed oil) used during Hysterosalpingography, a key step during the infertility workup; as well as Patent Blue V, endorsed for sentinel lymph node biopsy in patients with operable breast cancer.
The mission of Guerbet Interventional Imaging franchise is “to provide the medical community with innovative solutions to help physicians advance their patients treatments & outcomes”.
